Reducing the incidence and severity of post ERCP pancreatitis

Scandinavian Journal of Surgery

Volumn 94, Issue 2, 2005, Pages 112-116

  Murray, William R ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Post ERCP pancreatitis; Prevention of pancreatitis

Indexed keywords

CEFTAZIDIME; DICLOFENAC; GABEXATE; GLYCEROL NITRATE; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; RECOMBINANT INTERLEUKIN 10; SOMATOSTATIN;

ACUTE PANCREATITIS; CHOLELITHIASIS; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HUMAN; HYPERTENSION; IDIOPATHIC DISEASE; INCIDENCE; ODDI SPHINCTER; PAIN; PANCREAS DUCT; POSTOPERATIVE COMPLICATION; RECURRENT DISEASE; REVIEW; RISK FACTOR; SPHINCTEROTOMY; STENT;

EID: 23844481889     PISSN: 14574969     EISSN: None     Source Type: Journal    
DOI: 10.1177/145749690509400206     Document Type: Review

References (32)

1. McCune WS, Shork PE, Muscovitz H: Endoscopic cannulation of the ampulla of Vater: A preliminary report. Ann Surg 1968;167:752-756
2. Blackwood WD, Vennes J, Silvis S: Post endoscopic pancreatitis and hyperamylasaemia. Gastrointest Endosc 1973;20:56-58
3. LaFerla G, Gordon S, Archibald M, Murray WR: Hyperamylasaemia and acute pancreatitis following endoscopic retrograde cholangiopancreatography. Pancreas 1986;1:160-163
4. Freeman ML, Nelson DB, Sherman S, Haber GB, Herman ME, Dorsher PJ, et al: Complications of endoscopic biliary sphincterotomy. N Engl J Med 1996;335:909-918
5. Freeman ML, DiSario JA, Nelson DB, Fennerty MB, Lee JG, Bjorkman DJ, et al: Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc 2001;54: 425-434
6. Masci E, Toti G, Mariani A, Curioni S, Lomazzi A, Dinelli M, et al: Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol 2001;96: 417-423
7. Murray B, Carter R, Imrie C, Evans S, O'Suilleabhain C: Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography. Gastroenterology 2003;124:1786-1791
8. Cotton PB, Lehman G, Vennes J, Geenen JE, Russell RC, Meyers WC: Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointestinal Endosc 1991;37:383-393
9. Testoni PA, Bagnolo F, Caporuscio S, Lella F: Serum amylase measured four hours after endoscopic sphincterotomy is a reliable predictor of postprocedure pancreatitis. Am J Gastroenterol 1999;94:1235-1241
10. Freeman ML, Guda NM: Prevention of post-ERCP pancreatitis: a comprehensive review. Gastrointestinal Endosc 2004;59:845-864
11. Trap R, Adamsen S, Hart-Hansen O, Henriksen M: Severe and fatal complications after diagnostic and therapeutic ERCP: a prospective series of claims to insurance covering public hospitals. Endoscopy 1999;31:125-130
12. Tarnasky P, Palesch YY, Cunningham JT, Mauldin P, Cotton PB, Hawes RH: Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology 1998;11:1518-1524
13. Fogel EL, Eversman D, Jamidar P, Sherman S, Lehman GA: Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone. Endoscopy 2002;34:280-285
14. Vandervoort J, Soetikno RM, Tham TC, Wong RC, Ferrari AP Jr, Montes H, et al: Risk factors for complications after performance of ERCP. Gastrointest Endosc 2002;56:652-656
15. Rollhauser C, Johnson M, Al Kawas FH: Needle-knife papillotomy: a helpful and safe adjunct to endoscopic retrograde cholangiopancreatography in a selected population. Endoscopy 1998;30:691-696
16. Tarnasky PR, Cunningham JT, Hawes RH, Hoffman BJ, Uflacker R, Vujic I, et al: Transpapillary stenting of proximal biliary strictures: does biliary sphincterotomy reduce the risk of postprocedure pancreatitis? Gastrointest Endosc 1997;45:46-51
17. Goff JS: Common bile duct sphincter of Oddi stenting in patients with suspected sphincter dysfunction. Am J Gastroenterol 1995;90:586-589
18. Stefanidis G, Karamanolis G, Viazis N, Sgouros S, Papadopoulou E, Ntatsakis K, et al: A comparative study of postendoscopic sphincterotomy complications with various types of electrosurgical current in patients with choledocholithiasis. Gastrintest Endosc 2003;57:192-197
19. Norton ID, Gostout CJ, Baron TH, Geller A, Petersen BT, Wiersema MJ: Safety and outcome of endoscopic snare excision of the major duodenal papilla. Gastrointest Endosc 2002;56:239-243
20. Sherman S, Hawes RH, Troiano FP, Lehman GA: Pancreatitis following bile duct sphincter of Oddi manometry: utility of the aspirating catheter. Gastrointest Endosc 1992;38:347-350
21. Freeman ML: Post-ERCP pancreatitis: patient and technique-related risk factors. J Pancreas (online) 2002;3:169-176
22. Singh P, Das A, Isenberg G, Wong RC, Sivak MV, Agrawal D, et al: Does prophylactic stent placement reduce the risk of post ERCP acute pancreatitis? A meta-analysis of controlled trials. Gastrointest Endosc 2004;60:544-550
23. Loperfido S, Angelini G, Benedetti G, Chilovi F, Costan F, De Berardinis F, et al: Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 1998;48:1-10
24. Testoni PA: Pharmacological prevention of post-ERCP pancreatitis: the facts and the fiction. J Pancreas (online) 2004;5:171-178
25. Andruilli A, Clemente R, Solmi L, Terruzzi V, Suriani R, Sigillito A, et al: Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomised clinical trial. Gastrointest Endosc 2002;56:488-495
26. Arvanitidis D, Anagnostopolous GK, Giannopolous D, Pantes A, Agaritsi R, Margantinis G, et al: Can somatostatin prevent post-ERCP pancreatitis? Results of a randomised controlled trial. J Gastroenterol Hepatol 2004;19:278-282
27. Singh P, Lee T, Davidoff S, Bank S: Efficacy of Interleukin 10 (IL10) in the prevention of post-ERCP pancreatitis: a meta-analysis (Abstract). Gastrointest Endosc 2002;55:AB150
28. Sudhindran S, Bromwich E, Edwards PR: Prospective randomised double-blind placebo-controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis. Br J Surg 2001;88:1178-1182
29. Moreto M, Zaballa M, Casado I, Merino O, Rueda M, Ramirez K, et al: Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis: a randomised double-blind trial. Gastrointest Endosc 2003;57:1-7
30. Raty S, Sand J, Pulkkinen M, Matikainen M, Nordback I: Post-ERCP pancreatitis: reduction by routine antibiotics. J Gastrointest Surg 2001;5:339-345
31. Mäkelä A, Kuusi T, Schröder T: Inhibition of serum phospholipase-A2 in acute pancreatitis by pharmacological agents in vitro. Scand Clin Lab Invest 1997;57:401-408
32. MacKay CK, Murray WR: Can a 2 hour serum amylase estimation predict post ERCP acute pancreatitis? (Abstract). Gut 1994;35:S35